Clinical trial
Ipratropium Spray for Drooling Saliva in Parkinson's Disease
NCT00296946 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00296946 |
|---|---|
| Title | Ipratropium Spray for Drooling Saliva in Parkinson's Disease |
| Official title | Phase II Clinical Trial of Ipratropium Bromide Spray as a Treatment for Sialorrhea in Patients With Parkinson's Disease |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Parkinson's Disease Foundation |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | ipratropium bromide (drug) |
| Enrollment | 20 |
| Start date | Nov 1, 2004 |
| Completion | Jun 1, 2006 |
| First posted | Feb 27, 2006 |
| Last update posted | Feb 20, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: